Home » Topics » Disease categories and therapies » Urology

Urology
RSS

KMD-3213: binding kinetics and pharmacological activity correlated in vivo

Oct. 25, 2000

Vivus withdraws Alibra NDA

Oct. 23, 2000

New series of PDE5 inhibitors and their use described by Sanofi-Synthelabo

Oct. 19, 2000

Abbott researchers design novel water-soluble K+ channel openers

Oct. 17, 2000

Novel 5-HT reuptake inhibitors specifically claimed for use in premature ejaculation

Oct. 16, 2000

U.K. authorities clear new ED treatment for launch

Oct. 16, 2000

NitroMed describes improved methods of treating sexual dysfunction

Oct. 13, 2000

Mechanism of potential new treatment for erectile dysfunction elucidated

Oct. 13, 2000

Role for rho kinase inhibitors in the management of ED

Oct. 11, 2000

Synaptic's alpha1-adrenoceptors and BPH patents licensed to R.W. Johnson

Oct. 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.